Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Braybrooke EL"'
Autor:
Nixon IDG; Medicinal Chemistry, Oncology R&D, AstraZeneca, Charter Way, Macclesfield SK10 2NA, United Kingdom., Bateman JM; Medicinal Chemistry, Oncology R&D, AstraZeneca, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Michaelides IN; Hit Discovery, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom., Fairley G; Medicinal Chemistry, Oncology R&D, AstraZeneca, Charter Way, Macclesfield SK10 2NA, United Kingdom., Pemberton MJ; Medicinal Chemistry, Oncology R&D, AstraZeneca, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Braybrooke EL; Medicinal Chemistry, Oncology R&D, AstraZeneca, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Sutton K; Medicinal Chemistry, Oncology R&D, AstraZeneca, Charter Way, Macclesfield SK10 2NA, United Kingdom., Lindsay-Scott PJ; Medicinal Chemistry, Oncology R&D, AstraZeneca, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.
Publikováno v:
The Journal of organic chemistry [J Org Chem] 2024 Dec 20; Vol. 89 (24), pp. 18301-18312. Date of Electronic Publication: 2024 Dec 10.
Autor:
Hayhow TG; Oncology R&D, AstraZeneca, Cambridge, UK. thomas.hayhow@astrazeneca.com., Williamson B; Oncology R&D, AstraZeneca, Cambridge, UK., Lawson M; Oncology R&D, AstraZeneca, Cambridge, UK., Cureton N; Oncology R&D, AstraZeneca, Cambridge, UK., Braybrooke EL; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell A; Pharmaceutical Sciences, AstraZeneca, Cambridge, UK., Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge, UK., Cheraghchi-Bashi A; Oncology R&D, AstraZeneca, Cambridge, UK., Chiarparin E; Oncology R&D, AstraZeneca, Cambridge, UK., Diène CR; Oncology R&D, AstraZeneca, Cambridge, UK., Fallan C; Oncology R&D, AstraZeneca, Cambridge, UK., Fisher DI; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Goldberg FW; Oncology R&D, AstraZeneca, Cambridge, UK., Hopcroft L; Oncology R&D, AstraZeneca, Cambridge, UK., Hopcroft P; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Jackson A; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Kettle JG; Oncology R&D, AstraZeneca, Cambridge, UK., Klinowska T; Oncology R&D, AstraZeneca, Cambridge, UK., Künzel U; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Lamont G; Oncology R&D, AstraZeneca, Cambridge, UK., Lewis HJ; Oncology R&D, AstraZeneca, Cambridge, UK., Maglennon G; Oncology R&D, AstraZeneca, Cambridge, UK., Martin S; Oncology R&D, AstraZeneca, Cambridge, UK., Gutierrez PM; Oncology R&D, AstraZeneca, Cambridge, UK., Morrow CJ; Oncology R&D, AstraZeneca, Cambridge, UK., Nikolaou M; Oncology R&D, AstraZeneca, Cambridge, UK., Nissink JWM; Oncology R&D, AstraZeneca, Cambridge, UK., O'Shea P; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Polanski R; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Schade M; Oncology R&D, AstraZeneca, Cambridge, UK., Scott JS; Oncology R&D, AstraZeneca, Cambridge, UK., Smith A; Oncology R&D, AstraZeneca, Cambridge, UK., Weber J; Oncology R&D, AstraZeneca, Cambridge, UK., Wilson J; Oncology R&D, AstraZeneca, Cambridge, UK., Yang B; Oncology R&D, AstraZeneca, Waltham, MA, USA., Crafter C; Oncology R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
Communications biology [Commun Biol] 2024 May 13; Vol. 7 (1), pp. 563. Date of Electronic Publication: 2024 May 13.
Autor:
Cumming IA; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom. Electronic address: iain.cumming@astrazeneca.com., Degorce SL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Aagaard A; Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden., Braybrooke EL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Davies NL; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Diène CR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Eatherton AJ; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Felstead HR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Groombridge SD; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Lenz EM; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Li Y; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176 PR China., Nai Y; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176 PR China., Pearson S; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Robb GR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Scott JS; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Steward OR; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge Science Park, Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Wu C; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176 PR China., Xue Y; Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-431 83 Mölndal, Sweden., Zhang L; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176 PR China., Zhang Y; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176 PR China.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2022 Jun 01; Vol. 63, pp. 116729. Date of Electronic Publication: 2022 Apr 02.
Autor:
LEAL, Claudia1 cleal@uc.cl, IVANECKY, Peter2 iptr@gmx.com
Publikováno v:
Scripta Theologica. aug2019, Vol. 51 Issue 2, p367-394. 28p.
Publikováno v:
Oncology Reports; Jun2024, Vol. 51 Issue 6, pN.PAG-N.PAG, 1p
Autor:
Joseph Pearce
Tras años de meticulosa investigación y acceso al patrimonio literario de G.K. Chesterton, Joseph Pearce presenta la biografía de este gigante literario del siglo XX, proporcionando una gran cantidad de información importante sobre el escritor qu
Autor:
Robert Louis Stevenson
Primera entrega de los ensayos reunidos del autor de La isla del tesoro. Empezamos con su universo literario. La arquitectura de un escritor. Narrador inolvidable, poeta valioso, viajero y acuñador de anécdotas biográficas, para conocer completame